Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

Unicycive Therapeutics (UNCY)

Unicycive Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:UNCY
DateTimeSourceHeadlineSymbolCompany
25/06/202412:30GlobeNewswire Inc.Unicycive Therapeutics Achieves Study Objective in Oxylanthanum Carbonate (OLC) Pivotal Clinical TrialNASDAQ:UNCYUnicycive Therapeutics Inc
28/05/202412:03GlobeNewswire Inc.Unicycive Therapeutics Delivers Multiple Presentations on Oxylanthanum Carbonate (OLC) and UNI-494 at the European Renal Association CongressNASDAQ:UNCYUnicycive Therapeutics Inc
23/05/202412:03GlobeNewswire Inc.Unicycive Therapeutics to Participate in a Fireside Chat at the Lytham Partners Spring 2024 Investor ConferenceNASDAQ:UNCYUnicycive Therapeutics Inc
15/05/202412:03GlobeNewswire Inc.Unicycive Therapeutics Presents Bioequivalence Data on Oxylanthanum Carbonate (OLC) at the National Kidney Foundation Spring Clinical MeetingNASDAQ:UNCYUnicycive Therapeutics Inc
13/05/202421:28Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:UNCYUnicycive Therapeutics Inc
13/05/202421:16GlobeNewswire Inc.Unicycive Announces First Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:UNCYUnicycive Therapeutics Inc
13/05/202421:06Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:UNCYUnicycive Therapeutics Inc
08/05/202421:05Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:UNCYUnicycive Therapeutics Inc
10/04/202412:03GlobeNewswire Inc.Unicycive Therapeutics to Present at the Noble Capital Markets Emerging Growth Virtual Healthcare Equity ConferenceNASDAQ:UNCYUnicycive Therapeutics Inc
28/03/202420:15GlobeNewswire Inc.Unicycive Therapeutics Announces Full Year 2023 Financial Results and Provides Business UpdateNASDAQ:UNCYUnicycive Therapeutics Inc
25/03/202411:03GlobeNewswire Inc.Unicycive Therapeutics to be Featured in Multiple Presentations at the Upcoming European Renal Association CongressNASDAQ:UNCYUnicycive Therapeutics Inc
14/03/202411:03GlobeNewswire Inc.Unicycive Announces $50 Million Private PlacementNASDAQ:UNCYUnicycive Therapeutics Inc
13/03/202411:03GlobeNewswire Inc.Unicycive Therapeutics Delivers Both an Oral and Poster Presentation on UNI-494 at the AKI and CRRT ConferenceNASDAQ:UNCYUnicycive Therapeutics Inc
07/03/202421:12GlobeNewswire Inc.Unicycive Therapeutics Completes Enrollment in Pivotal Clinical Trial for Oxylanthanum Carbonate (OLC)NASDAQ:UNCYUnicycive Therapeutics Inc
04/03/202412:03GlobeNewswire Inc.Unicycive Therapeutics Announces Orphan Drug Designation Granted for UNI-494 by the U.S. Food and Drug Administration for the Prevention of Delayed Graft Function in Kidney Transplant PatientsNASDAQ:UNCYUnicycive Therapeutics Inc
21/02/202421:06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:UNCYUnicycive Therapeutics Inc
14/02/202412:03GlobeNewswire Inc.Unicycive Therapeutics to Present Two Posters on Oxylanthanum Carbonate (OLC) at the Upcoming National Kidney Foundation Spring Clinical MeetingNASDAQ:UNCYUnicycive Therapeutics Inc
29/01/202412:03GlobeNewswire Inc.Unicycive Therapeutics Announces Both an Oral and Poster Presentation to be Delivered on UNI-494 at the Upcoming AKI and CRRT ConferenceNASDAQ:UNCYUnicycive Therapeutics Inc
23/01/202412:03GlobeNewswire Inc.Unicycive Therapeutics Issues Shareholder Letter to Highlight Corporate Progress and Key Upcoming MilestonesNASDAQ:UNCYUnicycive Therapeutics Inc
22/01/202421:27Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:UNCYUnicycive Therapeutics Inc
18/12/202312:03GlobeNewswire Inc.Unicycive Therapeutics Announces Enrollment of First Patient in Pivotal Clinical Trial for Oxylanthanum Carbonate (OLC) in Patients with Chronic Kidney Disease on DialysisNASDAQ:UNCYUnicycive Therapeutics Inc
08/12/202321:36Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:UNCYUnicycive Therapeutics Inc
29/11/202312:03GlobeNewswire Inc.Unicycive Therapeutics to Participate in Two Investor Conferences in December 2023NASDAQ:UNCYUnicycive Therapeutics Inc
14/11/202321:20Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:UNCYUnicycive Therapeutics Inc
14/11/202321:15GlobeNewswire Inc.Unicycive Announces Third Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:UNCYUnicycive Therapeutics Inc
23/10/202316:12Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:UNCYUnicycive Therapeutics Inc
23/10/202312:03GlobeNewswire Inc.Unicycive Therapeutics Reaches Alignment with the FDA on Path to File New Drug Application for Oxylanthanum Carbonate (OLC)NASDAQ:UNCYUnicycive Therapeutics Inc
25/09/202321:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:UNCYUnicycive Therapeutics Inc
07/09/202321:33Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:UNCYUnicycive Therapeutics Inc
07/09/202321:05Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:UNCYUnicycive Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:UNCY

Your Recent History

Delayed Upgrade Clock